JENNIE GARDNER: Open Payments
NPI 1790869071 · FRENCHBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 41 payments from 18 companies in 2025. Trend: 2023 $294 · 2024 $993 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $105 |
| Novo Nordisk Inc | 5 | $101 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $62 |
| Dexcom, Inc. | 2 | $44 |
| Corcept Therapeutics | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $33 |
Products named: UBRELVY, Kerendia, CAPLYTA, AUSTEDO XR, Dexcom G6 Transmitter, Wegovy, Korlym, REXULTI.
Industry payments across KY — which companies pay providers there.
